Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S. L. Romero Guillena"'
Publikováno v:
European Psychiatry, Vol 67, Pp S751-S752 (2024)
Introduction Relapse prevention is crucial in patients with schizophrenia, as repeated episodes can worsen psychopathology and functionality. There is strong evidence of antipsychotics efficacy in preventing relapse; however, non-compliance rates in
Externí odkaz:
https://doaj.org/article/5d62ed5d3cbe4afcb04526b0371e42b9
Publikováno v:
European Psychiatry, Vol 67, Pp S752-S752 (2024)
Introduction Relapse prevention is critical because psychopathology and functionality can worsen in patients with schizophrenia because the repeated episodes and we have strong evidence of antipsychotics efficacy for relapse prevention, but nonadhere
Externí odkaz:
https://doaj.org/article/597005a1ebfb4077a42a21a7cc413100
Publikováno v:
European Psychiatry, Vol 66, Pp S1086-S1087 (2023)
Introduction Relapse prevention is critical because psychopathology and functionality can worsen in patients with schizophrenia because the repeated episodes and we have strong evidence of antipsychotics efficacy for relapse prevention, but nonadhere
Externí odkaz:
https://doaj.org/article/427fa5c73ae840b5a4f842c3dcdd8d68
Autor:
S. L. Romero Guillena, B. O. Plasencia Garcia de Diego, J. Gomez Gonzalez, F. Gotor Sánchez-Luengo
Publikováno v:
European Psychiatry, Vol 66, Pp S487-S487 (2023)
Introduction Paliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and safety to Paliperidone Palmitate 1-month (PP1M) (Carpiniello et al. Drug Des. Devel. Ther.
Externí odkaz:
https://doaj.org/article/9246e1daee34454a9148c79cac9333ed